MedTrace Logo

Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry

NCT03667391 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-04-27

No results posted yet for this study

Summary

The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is difficult for numerous reasons and is related with a poor prognosis. In Taiwan, the incidence of CTEPH and its clinical features are unknown. This study aims at evaluating the prevalence, clinical characteristics, and management of CTEPH in a Taiwanese cohort.

Primary objective:

\- To investigate the geodemographics of CTEPH in Taiwan

Secondary objectives:

* To characterize the demographics and clinical presentation of patients with CTEPH
* To describe the real-world management and treatment outcome of patients with CTEPH
* To identify the risk factors of CTEPH
* To assess the relationship between risk factors/patients' characteristics and clinical outcomes for CTEPH
* To evaluate the prognosis of CTEPH in Taiwan using survival assessment

Conditions

  • The Geodemographics of CTEPH in Taiwan

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Hsao H Hsu, PhD · No.7, Chung Shan S. Rd.（Zhongshan S. Rd.）, Zhongzheng Dist., Taipei City 10002, Taiwan (R.O.C.)

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-17
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667391 on ClinicalTrials.gov